Faecal microbiota transplantation is better than probiotics for tissue regeneration of type 2 diabetes mellitus injuries in mice

References

• Abe, H., et al., 2013. Exendin-4 improves β-cell function in autophagy-deficient β-cells. Endocrinology, 154 (12), 4512–4524.
   PubMed Web of Science ®Google Scholar
• Alagiakrishnan, K., and Halverson, T., 2021. Holistic perspective of the role of gut microbes in diabetes mellitus and its management. World Journal of Diabetes, 12 (9), 1463–1478.
   Google Scholar
• Al-Jameel, S. S., 2021. Association of diabetes and microbiota: an update. Saudi journal of biological sciences, 28 (8), 4446–4454.
   Google Scholar
• Amato, A., et al., 2014. Exogenous glucagon-like peptide 1 reduces contractions in human colon circular muscle. The journal of endocrinology, 221 (1), 29–37.
   Google Scholar
• Bakir-Gungor, B., et al., 2021. Discovering potential taxonomic biomarkers of type 2 diabetes from human gut microbiota via different feature selection methods. Frontiers in microbiology, 12, 628426.
   Google Scholar
• Berchtold, L.A., et al., 2016. Cytokines and pancreatic β-cell apoptosis. Advances in clinical chemistry, 75, 99–158.
   Web of Science ®Google Scholar
• Ciesielska, A., Matyjek, M., and Kwiatkowska, K., 2021. TLR4 and CD14 trafficking and its influence on LPS-induced pro-inflammatory signaling. Cellular and molecular life sciences: CMLS, 78 (4), 1233–1261.
   PubMed Web of Science ®Google Scholar
• Cunha, D.A., et al., 2009. Glucagon-like peptide-1 agonists protect pancreatic beta-cells from lipotoxic endoplasmic reticulum stress through upregulation of BiP and JunB. Diabetes, 58 (12), 2851–2862.
   PubMed Web of Science ®Google Scholar
• D’Alessio, D., 2016. Is glp-1 a hormone: whether and when? Journal of diabetes investigation, 7 (Suppl 1), 50–55.
   PubMedGoogle Scholar
• Goyal, O., et al., 2020. Saroglitazar in patients with non-alcoholic fatty liver disease and diabetic dyslipidemia: a prospective, observational, real world study. Scientific reports, 10 (1), 21117.
   Google Scholar
• Grasset, E., et al., 2022. Gut microbiota dysbiosis of type 2 diabetic mice impairs the intestinal daily rhythms of glp-1 sensitivity. Acta diabetologica, 59 (2), 243–258.
   Google Scholar
• Han, X., et al., 2021. Kazak faecal microbiota transplantation induces short-chain fatty acids that promote glucagon-like peptide-1 secretion by regulating gut microbiota in db/db mice. Pharmaceutical biology, 59 (1), 1077–1087.
   PubMed Web of Science ®Google Scholar
• Han, Y.-H., et al., 2021. Enterically derived high-density lipoprotein estrains liver injury through the portal vein. Science, 373 (6553), eabe6729.
   Web of Science ®Google Scholar
• He, W., et al., 2019. Tlr4 triggered complex inflammation in human pancreatic islets. Biochimica et biophysica acta. molecular basis of disease, 1865 (1), 86–97.
   Google Scholar
• He, W., Yuan, T., and Maedler, K. A.-O., 2019. Macrophage-associated pro-inflammatory state in human islets from obese individuals. Nutrition & diabetes, 9 (1), 36.
   Google Scholar
• Hsieh, Y. C., et al., 2021. Eritoran attenuates hepatic inflammation and fibrosis in mice with chronic liver injury. Cells, 10 (6), 1562.
   Google Scholar
• Iacono, A., et al., 2011. Probiotics as an emerging therapeutic strategy to treat NAFLD: focus on molecular and biochemical mechanisms. The journal of nutritional biochemistry, 22 (8), 699–711.
   PubMed Web of Science ®Google Scholar
• Inoue, H., et al., 2018. Signaling between pancreatic β cells and macrophages via s100 calcium-binding protein a8 exacerbates β-cell apoptosis and islet inflammation. The Journal of biological chemistry, 293 (16), 5934–5946.
   PubMed Web of Science ®Google Scholar
• Khare, P., et al., 2021. Allicin, a dietary trpa1 agonist, prevents high fat diet-induced dysregulation of gut hormones and associated complications. Food & function, 12 (22), 11526-11536.
   Google Scholar
• Li, L., et al., 2011. Nuclear factor high-mobility group box1 mediating the activation of toll-like receptor 4 signaling in hepatocytes in the early stage of nonalcoholic fatty liver disease in mice. Journal of Clinical and experimental hepatology, 1 (2), 123–124.
   Google Scholar
• Liu, S., et al., 2022. Clinical significance of high mobility group box 1/toll-like receptor 4 in obese diabetic patients. Endocrine journal, 69 (3), 235–242.
   Google Scholar
• Lytrivi, M., et al., 2020. Recent insights into mechanisms of β-cell lipo- and glucolipotoxicity in type 2 diabetes. Journal of molecular biology, 432 (5), 1514–1534.
   PubMed Web of Science ®Google Scholar
• Masini, M., et al., 2017. Ultrastructural alterations of pancreatic beta cells in human diabetes mellitus. Diabetes/metabolism research and reviews, 33 (6), e2894.
   Web of Science ®Google Scholar
• Muñoz-Provencio, D., et al., 2009. Adhesion properties of Lactobacillus casei strains to resected intestinal fragments and components of the extracellular matrix. Archives of microbiology, 191 (2), 153–161.
   PubMed Web of Science ®Google Scholar
• Netyazhenko, V., and Bazhenova, N., 2021. The influence of hypercholesterolemia and concomitant statin therapy on the state of platelet-plasma hemostasis in patients with essential hypertension and non-alcoholic fatty liver disease. Georgian medical news, (318), 75–81.
   Google Scholar
• Ramakrishna, B.S., 2009. Probiotic-induced changes in the intestinal epithelium: implications in gastrointestinal disease. Tropical gastroenterology: official journal of the digestive diseases foundation, 30 (2), 76–85.
   PubMedGoogle Scholar
• Tiderencel, K. A.-O., Hutcheon, D. A., and Ziegler, J., 2020. Probiotics for the treatment of type 2 diabetes: a review of randomized controlled trials. Diabetes/metabolism research and reviews, 36 (1), e3213.
   Google Scholar
• Wang, R., et al., 2018. Genetically obese human gut microbiota induces liver steatosis in germ-free mice fed on normal diet. Frontiers in microBiology, 9, 1602,
   PubMed Web of Science ®Google Scholar
• Wu, M.-J., et al., 2021. Influencing factors for hepatic fat accumulation in patients with type 2 diabetes mellitus. World journal of clinical cases, 9 (26), 7717–7728.
   PubMed Web of Science ®Google Scholar
• Xu, Y., et al., 2021. Hypomorphic ASGR1 modulates lipid homeostasis via INSIG1-mediated SREBP signaling suppression. JCI insight, 6 (19), e147038.
   Web of Science ®Google Scholar
• Yan, F., et al., 2019. Lactobacillus acidophilus alleviates type 2 diabetes by regulating hepatic glucose, lipid metabolism and gut microbiota in mice. Food & function, 10 (9), 5804–5815.
   PubMed Web of Science ®Google Scholar